Kousaku Ohno

Title: Kousaku Ohno: Innovator in Glycolipid Metabolic Disorder Treatments

Introduction

Kousaku Ohno is a notable inventor based in Yonago, Japan. He has made significant contributions to the field of biomedical research, particularly in the treatment of glycolipid metabolic disorders. With a total of two patents to his name, Ohno's work has the potential to impact many lives.

Latest Patents

Ohno's latest patents include innovative methods for treating glycolipid metabolic disorders. His patents focus on a carba-sugar amine derivative and a glycolipid metabolic disorder treating agent containing the same as an active ingredient. These inventions aim to stabilize β-galactosidase and β-glucocerebrosidase, which are crucial for treating conditions such as GM1 gangliosidosis, Morquio-B disease, Krabbe's disease, and Gaucher's disease. The carba-sugar amine derivative is represented by specific chemical formulas and is designed to regenerate the activity of the enzymes involved in these metabolic processes.

Career Highlights

Kousaku Ohno is associated with Seikagaku Corporation, where he has been able to apply his research in a practical setting. His work has contributed to advancements in the treatment of serious metabolic disorders, showcasing his dedication to improving patient outcomes through innovative solutions.

Collaborations

Ohno has collaborated with esteemed colleagues such as Seiichiro Ogawa and Yoshiyuki Suzuki. These partnerships have likely enhanced the research and development of his patented technologies, fostering a collaborative environment for innovation.

Conclusion

Kousaku Ohno's contributions to the field of glycolipid metabolic disorder treatments highlight his role as a significant inventor. His innovative patents and collaborations reflect his commitment to advancing medical science and improving the lives of those affected by metabolic disorders.